Except for MDM2 and MDM4 from the TP53 pathway, which are oncogenes that can acquire copy number gains in certain cancers, the selected DDR genes are tumour suppressor genes that can undergo inactivating mutations or copy number loss in cancer. The gene discussed is MDM2; the disease is cancer.